UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000015105
Receipt No. R000017582
Scientific Title A randomized phase 2 trial which investigate the most effective administration method of antithrombin (AT) products in patients with disseminated intravascular coagulation (DIC) associated with sepsis during treatment for advanced pancreatic and biliary cancer.
Date of disclosure of the study information 2014/09/10
Last modified on 2019/04/08 12:59:59

No. Disposal Last modified on Item of update
1 Insert 2014/09/10 11:58:57
2 Update 2014/09/10 16:31:31 Public title
Acronym
Acronym
3 Update 2014/09/10 16:35:09 Condition
Narrative objectives1
Primary outcomes
Key secondary outcomes
4 Update 2014/09/10 16:42:14 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Key inclusion criteria
Key exclusion criteria
5 Update 2014/09/10 16:43:24 Recruitment status
6 Update 2017/05/16 19:19:46 Randomization unit
7 Update 2017/05/16 19:20:07 Name of primary sponsor
Organization
8 Update 2019/04/08 12:59:59 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date


Contact us.